Drug
Lapaquistat Acetate And Fenofibrate
Lapaquistat Acetate And Fenofibrate: highest development phase Phase 2, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lapaquistat acetate and fenofibrate NCT00813527 | Phase 2 | Hyperlipidemias |
Latest
No recent events.
Follow Lapaquistat Acetate And Fenofibrate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.